Which of the following are medications used to treat asthma: parasympatholytic (anticholinergic) drugs, corticosteroids, dactylitis, amiodarone, or sulfonylureas?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications Used to Treat Asthma

The correct answers are (a) parasympatholytic drugs and (b) corticosteroids—both are established asthma medications, while dactylitis is a symptom (not a drug), amiodarone is an antiarrhythmic, and sulfonylureas are diabetes medications. 1

Corticosteroids (Option B) - CORRECT

Corticosteroids are the most consistently effective long-term control medications at all steps of care for persistent asthma, superior to any other single medication. 1, 2

Mechanism and Role

  • Inhaled corticosteroids (ICS) reduce airway hyperresponsiveness, inhibit inflammatory cell migration and activation, and block late-phase allergic reactions to allergens 1, 2
  • They are the preferred controller medication for all patients with persistent asthma, more effective than leukotriene receptor antagonists or any other single long-term control medication 1
  • Oral systemic corticosteroids (prednisone, prednisolone, methylprednisolone) are used for moderate to severe asthma exacerbations and for patients requiring step 6 care (severe persistent asthma) 1, 2

Available Formulations

  • ICS options include: beclomethasone, budesonide, fluticasone, flunisolide, mometasone, ciclesonide, and triamcinolone 1, 3
  • Delivered via metered-dose inhalers (MDIs) with spacers or dry powder inhalers (DPIs) 3

Parasympatholytic (Anticholinergic) Drugs (Option A) - CORRECT

Anticholinergic agents, specifically ipratropium bromide, are used in asthma treatment, though they play a more limited role compared to beta-2 agonists and corticosteroids. 4, 5

Clinical Use

  • Ipratropium bromide is available in HFA-propelled MDI preparations 1
  • It can provide additional benefit when combined with beta-2 agonists in acute severe asthma, though routine use is not recommended for all acute exacerbations 5
  • Anticholinergics have slower onset and longer duration of action than inhaled beta-2 agonists, with virtually no side effects 4
  • They are more useful for COPD than for chronic asthma management 4

Incorrect Options

Dactylitis (Option C) - INCORRECT

  • Dactylitis is a clinical symptom (swelling of fingers or toes), not a medication [@General Medicine Knowledge@]
  • This is a distractor answer with no relevance to asthma pharmacotherapy

Amiodarone (Option D) - INCORRECT

  • Amiodarone is an antiarrhythmic medication used for cardiac arrhythmias, not asthma [@General Medicine Knowledge@]
  • It has no role in asthma management and can actually cause pulmonary toxicity

Sulfonylureas (Option E) - INCORRECT

  • Sulfonylureas are oral hypoglycemic agents used to treat type 2 diabetes mellitus, not asthma [@General Medicine Knowledge@]
  • They stimulate insulin secretion from pancreatic beta cells and have no bronchodilator or anti-inflammatory properties

Additional Key Asthma Medications (Not Listed in Options)

For completeness, other major asthma medications include:

  • Beta-2 agonists (short-acting like albuterol; long-acting like salmeterol and formoterol) - most effective bronchodilators for rapid symptom relief 1, 4
  • Leukotriene modifiers (montelukast, zafirlukast, zileuton) - alternative but not preferred therapy for mild persistent asthma 1
  • Immunomodulators (omalizumab) - for severe persistent asthma with allergic component 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Asthma Management with Corticosteroids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Inhaled Corticosteroids for Asthma Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.